Skip to main content
SpringerLink
Log in

Orengedokuto exerts anti-allergic effects via inhibition of effector T cell activation in a murine model of contact hypersensitivity

  • Original Paper
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

Orengedokuto (OGT) is a Kampo prescription that has been used for the treatment of inflammation, hypertension, gastrointestinal disorders, and liver and cerebrovascular diseases. It is also used for the treatment of skin diseases such as urticaria and atopic dermatitis. We previously studied its anti-allergic effects of OGT on the murine model of 2,4,6-trinitrochlorobenzene (TNCB)-induced contact hypersensitivity (CHS) and demonstrated that it significantly suppresses ear swelling in a dose-dependent manner. However, the mechanism underlying this activity remained unknown. Here, we sought to identify the mechanism involved. Using a murine model of TNCB-induced CHS, together with adoptive cell transfer experiments, we found that the anti-allergic effects of OGT may be due to the inhibition of effector T cell activation and not the induction and/or activation of regulatory T cells. Flow cytometry analysis revealed that oral administration of OGT suppressed the increase in CD8+CD44highCD62L+ cell number in draining lymph nodes (dLNs) of mice sensitized with 5% TNCB. Additionally, ex vivo experiments confirmed the suppressive effect of OGT on the activation of effector T cells, as interferon-γ (IFN-γ) production by cultured lymphocytes obtained from 5% TNCB-sensitized mice and stimulated with anti-CD3ε and anti-CD28 monoclonal antibodies was reduced by OGT administration. In conclusion, our finding suggests that OGT exerts anti-allergic effects by regulating the activation of effector T cells involved in inflammatory skin diseases such as atopic dermatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Hanifin JM, Rajika G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venerol (Stockholm) Suppl 92:44 – 47

  2. Cooper KD (1994) J Invest Dermatol 102:128–137

    Article  CAS  Google Scholar 

  3. Kabashima K (2013) New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 70:3–11

    Article  Google Scholar 

  4. Seegraber M, Srour J, Walter A, Knop M, Wollenberg A (2018) Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Phramacoll 11, https://doi.org/10.1080/17512433.2018.1449462

  5. Woo TE, Kuzel P (2019) Crisaborole 2% ointment (Eucrisa) for atopic dermatitis. Skin Therapy Lett 24:4–6

    PubMed  Google Scholar 

  6. Nakagawa H, Nemoto O, Igarashi A, Saeki H, Kaino H Nagata T (2020) Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study. J Am Acad Dermatol 82:823–831

  7. The ministry of Health, Labour and Welfare of Japan (2016) The Japanese pharmacopeia. The Ministry of Health, Labour and Welfare of Japan, Tokyo, pp 1752 – 1754

  8. Li Y, Xie J, Li Y, Yang Y, Yang L (2019) Literature data-based systems pharmacology uncovers the essence of “body fire” in traditional Chinese medicine: a case by Huang–Lian–Jie–Du–Tang. J Ethnopharmacol 237:266–285

    Article  Google Scholar 

  9. Nose M, Sakushima J, Harada D, Ogihara Y (1999) Comparison of immunopharmacological actions of 8 kinds of Kampo-hozais clinically used in atopic dermatitis on delayed-type hypersensitivity in mice. Biol Pharm Bull 22:48–54

    Article  CAS  Google Scholar 

  10. Gao XK, Fuseda K, Shibata T, Tanaka H, Inagaki N, Nagai H (2005) Kampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice. Evid Based Complement Alternat Med 2:191–199

    Article  Google Scholar 

  11. Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7:27–31

    Article  Google Scholar 

  12. Camp RL, Scheyninus A, Johansson C, Pure E (1993) CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178:497–507

    Article  CAS  Google Scholar 

  13. Gonda A, Gal I, Szanto S, Sarraj B, Glant TT, Hunyadi J Mikecz K (2005) CD44, but not L-selectin, is critically involved in leukocyte migration into the skin in a murine model of allergic dermatitis. Exp Dermatol 14: 700–708

  14. Nakashima D, Kabashima K, Sakabe J, Sugita K, Kobayashi T, Yoshiki R, Tokuda Y (2008) Impaired initiation of contact hypersensitivity by FT720. J Invest Dermatol 128:2833–2841

    Article  CAS  Google Scholar 

  15. Salluso F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708–712

    Article  Google Scholar 

  16. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM Antia R, Andrian UH, Ahmed R (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225–234

  17. Takeda K, Gelfannd EW (2009) Mouse models of allergic diseases. Cur Opinion Immunol 21:660–665

    Article  CAS  Google Scholar 

  18. Martel BC, Lovato P, Baümer W, Olivry, (2017) Translational animal model of atopic dermatitis for preclinical studies. Yale J Biol Med 90:389–402

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Kim D, Kobayashi T, Nagao K (2019) Research techniques made simple: mouse models of atopic dermatitis. J Invest Dermatol 139:984–990

    Article  CAS  Google Scholar 

  20. Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF (2009) Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64:1699–1714

    Article  CAS  Google Scholar 

  21. Bouloc A, Cavani A, Katz SI (1998) Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells. J Invest Dermatol 111:44–49

    Article  CAS  Google Scholar 

  22. Wang B, Fujisawa H, Zhuang L, Freed I, Howell BG, Shiahid S, Shivji GM, Mak TW, Sauder DN (2000) CD4+ Th1 and CD8+ Type 1 cytosolic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 165:6783–6790

    Article  CAS  Google Scholar 

  23. Okazaki F, Kanzaki H, Fujii K, Arata J, Akiba H, Tsuji K, Iwatsuki K (2002) Initial recruitment of interferon-γ-producing CD8+ effector cells, followed by infiltration of CD4+ cells in 2, 4, 6-trinotro-1-chrolobenzene (TNCB)-induced murine contact hypersensitivity. J Dermatol 29:699–708

    Article  Google Scholar 

  24. Christensen AD, Haase C (2011) Immunological mechanisms of contact hypersensitivity in mice. APMS 120:1–27

    Google Scholar 

  25. Chen Y, Xian YF, Loo S, Lai Z, Chan WY, Liu L, Lin ZX (2020) Huang-Lian-Jie-Du extract ameliorates atopic dermatitis-like skin lesions induced by 2,4-nitirobenzen in mice via suppression of MAPKs and NF-κB pathways. J Ethnopharmacol 249:112367

  26. Chen Y, Xian Y, Lai Z, Loo S, Chain WY, Lin ZX (2016) Anti-inflammatory and anti-allergic effects of Huang–Lian–Jie–Du extract: implication for atopic dermatitis treatment. J Ethnopharmacol 185:41–52

    Article  Google Scholar 

  27. Zeng H, Dou S, Zhao J, Fan S, Yuan X, Zhu S, Li L, Zhong W, Liu R (2011) The inhibitory activities of the components of Huang–Lian–Jie–Du–Tang (HLJIDT) on eicosanoid generation via lipoxygenase pathway. J Ethnopharmacol 135:561–568

    Article  CAS  Google Scholar 

  28. Oshima N, Narukawa Y, Hada N, Kiuchi F (2013) Quantitative analysis of anti-inflammatory activity of orengedokuto: importance of combination of flavonoids in inhibition of PGE2 production in mouse macrophage-like cell line J774.1. J Nat Med 67:281–288

    Article  CAS  Google Scholar 

  29. Oshima N, Shimizu T, Narukawa Y, Hada N, Kiuchi F (2018) Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production. J Nat Med 72:706–714

    Article  CAS  Google Scholar 

  30. Chi YS, Cheon BS, Kim HP (2001) Effect of wogonin, a plant flavone from Scutellariae Radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW264.7 cells. Biochem Pharmacol 61:1195–1203

    Article  CAS  Google Scholar 

  31. Yoon SB, Lee YJ, Park SK, Kim HC, Bae H, Kim HM, Ko SG, Choi HY, Oh MS, Park W (2009) Anti-inflammatory effects of Scutellariae baicalensis water extract on LPS-activated RAW264.7 macrophages. J Ethnopharmacol 125:286–290

    Article  Google Scholar 

  32. Akiyama H, Nose M, Takiguchi H, Sugiyama K, Tsutsui R, Hisaka S, Fuchino H, Inui T, Kawano N, Taguchi T, Kudo T, Kawahara N, Yoshimatsu K (2019) Mutagenetic and anti-allergic studies for evaluation of extracts of Coptis Rhizome produced by an artificial hydroponic system. J Nat Med 73:608–613

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacognosy, Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya, Aichi, 468-8503, Japan

    Atsushi Tsuge & Mitsuhiko Nose

  2. Department of Pharmacognosy, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya, Aichi, 468-8503, Japan

    Atsuki Watanabe, Yuki Kodama, Shinsuke Hisaka & Mitsuhiko Nose

Authors
  1. Atsushi Tsuge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atsuki Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuki Kodama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shinsuke Hisaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mitsuhiko Nose
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsuhiko Nose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 464 KB)

Supplementary file2 (DOCX 19 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsuge, A., Watanabe, A., Kodama, Y. et al. Orengedokuto exerts anti-allergic effects via inhibition of effector T cell activation in a murine model of contact hypersensitivity. J Nat Med 76, 144–151 (2022). https://doi.org/10.1007/s11418-021-01566-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-021-01566-2

Keywords

Search

Navigation